PDF(Pubmed)
Abstract：
Two cases are presented with coronavirus disease 19 (COVID-19)-related hiccups: one during initial presentation and one 10 days after COVID-19 diagnosis. Hiccups in both patients were resistant to treatment and responded only to chlorpromazine. COVID-19 patients may present with hiccups and also may have hiccups after treatment. Resistant hiccups without any underlying disease other than COVID-19 should be considered in association with COVID-19 and may respond well to chlorpromazine.
摘要：
2例与冠状病毒病19（COVID-19）相关的打嗝：一例在初次就诊时，一例在COVID-19诊断后10天。两名患者的打嗝对治疗有抵抗力，仅对氯丙嗪有反应。COVID-19患者可能出现打嗝，治疗后也可能出现打嗝。除COVID-19外，没有任何潜在疾病的抗性打嗝应考虑与COVID-19相关，并且可能对氯丙嗪反应良好。
